The Journal of Practical Medicine >
Application and progress of exhaled breath analysis technology in respiratory system diseases
Received date: 2024-05-25
Online published: 2024-11-25
Exhaled breath analysis technology is a non-invasive， painless， safe， convenient， and efficient detection method. It holds great promise in disease screening， clinical diagnosis， assessment of disease severity， formulation of treatment plans， and prediction of disease prognosis. In recent years， this technology has rapidly advanced and has become an important tool in the management of respiratory system diseases. This article aims to provide a brief overview of the clinical applications and research progress of common exhaled breath analysis technologies in respiratory system diseases such as airway chronic inflammatory diseases and airway infectious diseases.
Donglu LIANG , Libing. MA . Application and progress of exhaled breath analysis technology in respiratory system diseases[J]. The Journal of Practical Medicine, 2024 , 40(22) : 3124 -3129 . DOI: 10.3969/j.issn.1006-5725.2024.22.002
| 1 | GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations， 1990-2021： A systematic analysis for the Global Burden of Disease Study 2021［J］. Lancet， 2024， 403（10440）：2100-2132. |
| 2 | 中国医药教育协会慢性气道疾病专业委员会， 中国哮喘联盟. 呼出气一氧化氮检测及其在气道疾病诊治中应用的中国专家共识［J］. 中华医学杂志， 2021，101（38）：3092-3114. |
| 3 | KREIT J W. Volume Capnography in the Intensive Care Unit：Potential Clinical Applications［J］. Ann Am Thorac Soc， 2019，16（4）：409-420. doi:10.1513/annalsats.201807-502cme |
| 4 | GRASSIN-DELYLE S， ROQUENCOURT C， MOINE P， et al. Metabolomics of exhaled breath in critically ill COVID-19 patients：A pilot study［J］. EBioMedicine， 2021，63：103154. doi:10.1016/j.ebiom.2020.103154 |
| 5 | RICCO M， ZANIBONI A， SATTA E， et al. Potential Use of Exhaled Breath Condensate for Diagnosis of SARS-CoV-2 Infections：A Systematic Review and Meta-Analysis［J］. Diagnostics （Basel）， 2022，12（9）：2245. doi:10.3390/diagnostics12092245 |
| 6 | 中华医学会呼吸病学分会哮喘学组. 支气管激发试验临床应用中国专家共识（2024版）［J］. 中华医学杂志， 2024，104（22）：2031-2040. |
| 7 | 缪晔红， 沈莹莹， 魏源， 等. FeNO、外周血EOS计数及血清总IgE对支气管哮喘的联合诊断价值探讨［J］. 国际呼吸杂志， 2022，42（8）：583-588. |
| 8 | SONG W J， KIM H J， SHIM J S， et al. Diagnostic accuracy of fractional exhaled nitric oxide measurement in predicting cough-variant asthma and eosinophilic bronchitis in adults with chronic cough：A systematic review and meta-analysis［J］. J Allergy Clin Immunol， 2017，140（3）：701-709. doi:10.1016/j.jaci.2016.11.037 |
| 9 | 张星慧， 常晓悦. IL-8与FeNO在不同炎症表型的咳嗽变异性哮喘患者中的水平及临床意义［J］. 国际呼吸杂志， 2020，40（20）：1585-1591. |
| 10 | 梁桂菊， 陈碧， 朱洁晨， 等. 哮喘患者肺泡一氧化氮与小气道功能的相关性［J］. 实用医学杂志， 2022，38（6）：767-772. |
| 11 | ZENG G S， CHEN H， CHEN L C， et al. Clinical implications of concentration of alveolar nitric oxide in asthmatic and non-asthmatic subacute cough［J］. J Breath Res， 2021，16（1）. doi：10.1088/1752-7163/ac3616 . |
| 12 | TURNER S， COTTON S， WOOD J， et al. Reducing asthma attacks in children using exhaled nitric oxide （RAACENO） as a biomarker to inform treatment strategy： A multicentre， parallel， randomised， controlled， phase 3 trial［J］. Lancet Respir Med， 2022，10（6）：584-592. doi:10.1016/s2213-2600(21)00486-0 |
| 13 | FANG C， YANG L J， CHEN X J， et al. A clinical investigation into the usefulness of fractional exhaled nitric oxide in guiding glucocorticoid therapy in children with bronchial asthma［J］. J Physiol Pharmacol， 2022，73（4）. doi：10.26402/jpp.2022.4.09 . |
| 14 | HANIBUCHI M， MITSUHASHI A， KAJIMOTO T， et al. Clinical significance of fractional exhaled nitric oxide and periostin as potential markers to assess therapeutic efficacy in patients with cough variant asthma［J］. Respir Investig， 2023，61（1）：16-22. doi:10.1016/j.resinv.2022.10.006 |
| 15 | IKWU I， NICOLAS L G， MEHARI A， et al. Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older［J］. Respir Med， 2022，198：106879. doi:10.1016/j.rmed.2022.106879 |
| 16 | SU K C， KO H K， HSIAO Y H， et al. Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease：A Stratified， Randomized， Controlled Trial［J］. Arch Bronconeumol， 2022，58（8）：601-610. doi:10.1016/j.arbres.2021.11.013 |
| 17 | ZHANG C， ZHANG M， WANG Y， et al. Diagnostic value of fractional exhaled nitric oxide in differentiating the asthma-COPD overlap from COPD： A systematic review and meta-analysis［J］. Expert Rev Respir Med， 2022，16（6）：679-687. doi:10.1080/17476348.2022.2011221 |
| 18 | MONEDEIRO F， MONEDEIRO-MILANOWSKI M， RATIU I A， et al. Needle Trap Device-GC-MS for Characterization of Lung Diseases Based on Breath VOC Profiles［J］. Molecules， 2021，26（6）：1789. doi:10.3390/molecules26061789 |
| 19 | KIENHORST S， VAN AARLE M， JOBSIS Q， et al. The ADEM2 project： Early pathogenic mechanisms of preschool wheeze and a randomised controlled trial assessing the gain in health and cost-effectiveness by application of the breath test for the diagnosis of asthma in wheezing preschool children［J］. BMC Public Health， 2023，23（1）：629. doi:10.1186/s12889-023-15465-6 |
| 20 | SCHLEICH F N， ZANELLA D， STEFANUTO P H， et al. Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma［J］. Am J Respir Crit Care Med， 2019，200（4）：444-453. doi:10.1164/rccm.201811-2210oc |
| 21 | BRINKMAN P， WAGENER A H， HEKKING P P， et al. Identification and prospective stability of electronic nose （eNose）-derived inflammatory phenotypes in patients with severe asthma［J］. J Allergy Clin Immunol， 2019，143（5）：1811-1820. doi:10.1016/j.jaci.2018.10.058 |
| 22 | HOLZ O， WASCHKI B， WATZ H， et al. Breath volatile organic compounds and inflammatory markers in adult asthma patients：Negative results from the ALLIANCE cohort［J］. Eur Respir J， 2021，57（2）：2002127. doi:10.1183/13993003.02127-2020 |
| 23 | PERTZOV B， RONEN M， ROSENGARTEN D， et al. Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients［J］. Respir Res， 2021，22（1）：154. doi:10.1186/s12931-021-01747-3 |
| 24 | TALKER L， NEVILLE D， WIFFEN L， et al. Machine diagnosis of chronic obstructive pulmonary disease using a novel fast-response capnometer［J］. Respir Res， 2023，24（1）：150. doi:10.1080/15412555.2024.2321379 |
| 25 | SUN X， YANG W， GONG S， et al. Diagnostic value of volumetric capnography in patients with chronic cough variant asthma［J］. Clinics （Sao Paulo）， 2020，75：e1662. doi:10.6061/clinics/2020/e1662 |
| 26 | ABDULLAH A A， ZAHEDI F D， HUSAIN S， et al. Diagnostic Value and Clinical Application of Nasal Fractional Exhaled Nitric Oxide in Subjects with Allergic Rhinitis［J］. Am J Rhinol Allergy， 2023，37（3）：307-312. doi:10.1177/19458924221145084 |
| 27 | HACCURIA A， Van MUYLEM A， MALINOVSCHI A， et al. Small airways dysfunction： The link between allergic rhinitis and allergic asthma［J］. Eur Respir J， 2018，51（2）：1701749. doi:10.1183/13993003.01749-2017 |
| 28 | DRAGONIERI S， QUARANTA V N， CARRATU P， et al. Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma［J］. Biomarkers， 2019， 24（1）：70-75. doi:10.1080/1354750x.2018.1508307 |
| 29 | GUEST C， DEWHIRST S Y， LINDSAY S W， et al. Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections： An observational study［J］. J Travel Med， 2022，29（3）：taac043. |
| 30 | SHARMA R， ZANG W， TABARTEHFARAHANI A， et al. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant［J］. JAMA Netw Open， 2023， 6（2）：e230982. doi:10.1001/jamanetworkopen.2023.0982 |
| 31 | MYERS R， RUSZKIEWICZ D M， MEISTER A， et al. Breath testing for SARS-CoV-2 infection［J］. EBioMedicine， 2023， 92：104584. doi:10.1016/j.ebiom.2023.104584 |
| 32 | V R N， MOHAPATRA A K， V K U， et al. Post-COVID syndrome screening through breath analysis using electronic nose technology［J］. Anal Bioanal Chem， 2022，414（12）：3617-3624. doi:10.1007/s00216-022-03990-z |
| 33 | RYAN D J， TOOMEY S， MADDEN S F， et al. Use of exhaled breath condensate （EBC） in the diagnosis of SARS-COV-2 （COVID-19）［J］. Thorax， 2021，76（1）：86-88. doi:10.1136/thoraxjnl-2020-215705 |
| 34 | BETANCOR D， VALVERDE-MONGUE M， GOMEZ-LOPEZ A， et al. Evaluation of Fractional Exhaled Nitric Oxide During SARS-CoV-2 Infection［J］. J Investig Allergol Clin Immunol， 2022， 32（4）：301-303. doi:10.18176/jiaci.0762 |
| 35 | LIOR Y， YATZKAN N， BRAMI I， et al. Fractional exhaled Nitric Oxide （FeNO） level as a predictor of COVID-19 disease severity［J］. Nitric Oxide， 2022，124：68-73. doi:10.1016/j.niox.2022.05.002 |
| 36 | KARAALI R， CAKIR A， BORA E S， et al. The Evaluation of End Tidal Carbon Dioxide Values in Intubated Patients with COVID-19［J］. Acta Biomed， 2022，93（1）：e2022032. |
| 37 | GRAF J， PEREZ R， LOPEZ R. Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS［J］. J Crit Care， 2022，71：154095. doi:10.1016/j.jcrc.2022.154095 |
| 38 | ZETOLA N M， MODONGO C， MATSIRI O， et al. Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples［J］. J Infect， 2017，74（4）：367-376. doi:10.1016/j.jinf.2016.12.006 |
| 39 | SAKTIAWATI A， PUTERA D D， SETYAWAN A， et al. Diagnosis of tuberculosis through breath test：A systematic review［J］. EBioMedicine， 2019，46：202-214. doi:10.1016/j.ebiom.2019.07.056 |
| 40 | CORONEL T R， IJDEMA D， GOMEZ C， et al. The electronic nose as a rule-out test for tuberculosis in an indigenous population［J］. J Intern Med， 2021，290（2）：386-391. doi:10.1111/joim.13281 |
| 41 | LOPEZ J W， LOADER M I， SMITH D， et al. Exhaled Nitric Oxide is Not a Biomarker for Pulmonary Tuberculosis［J］. Am J Trop Med Hyg， 2018，98（6）：1637-1639. doi:10.4269/ajtmh.17-0425 |
| 42 | AHMED W M， FENN D， WHITE I R， et al. Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients［J］. Clin Infect Dis， 2023， 76（6）：1059-1066. doi:10.1093/cid/ciac859 |
/
| 〈 |
|
〉 |